iTeos Therapeutics, Inc. (ITOS) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist EcoR1 Capital, LLC mit 7,388,978 Aktien. Weitere bedeutende Anteilseigner sind RA CAPITAL MANAGEMENT, L.P. und GADICKE ANSBERT.
In den letzten 12 Monaten haben Insider 15 Transaktionen in ITOS Aktien getätigt — 2 Käufe (im Wert von $38.69M) und 10 Verkäufe (im Wert von $21.47M). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
ITOS Insider-Beteiligungen
Größter Aktionär
EcoR1 Capital, LLC
7,388,978 Aktien
Käufe (12 Monate)
2
$38.69M Wert
Verkäufe (12 Monate)
10
$21.47M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Ecor1 Capital, Llc |
10 Percent Owner |
7,388,978 |
2025-05-16 |
|
| 2 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
5,714,285 |
2024-05-14 |
|
| 3 |
Gadicke Ansbert |
Other: Former 10% Owner |
3,452,797 |
2025-05-15 |
|
| 4 |
Lewis Joseph |
Director |
3,142,058 |
2022-03-18 |
|
| 5 |
Boxer Capital, Llc |
Other: See Remarks |
2,946,915 |
2024-05-14 |
|
| 6 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
2,108,594 |
2025-05-15 |
|
| 7 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
2,108,594 |
2025-05-15 |
|
| 8 |
Call Matthew |
Chief Operating Officer |
145,000 |
2025-03-11 |
|
| 9 |
Detheux Michel |
Chief Executive Officer |
135,903 |
2025-03-11 |
|
| 10 |
Lager Joanne Jenkins |
Chief Medical Officer |
130,000 |
2023-03-10 |
|
| 11 |
Gall Matthew |
Chief Financial Officer |
89,429 |
2025-03-11 |
|
| 12 |
Feltquate David |
Chief Medical Officer |
47,000 |
2024-12-06 |
|
| 13 |
Mcgrath Yvonne |
Chief Scientific Officer |
46,300 |
2025-03-11 |
|
| 14 |
Lee David K |
Director |
24,200 |
2024-06-13 |
|
| 15 |
Desimone Jill |
Director |
24,200 |
2024-06-13 |
|
| 16 |
Ho Tony W |
Director |
24,200 |
2024-06-13 |
|
| 17 |
Davis Aaron I. |
Director |
24,200 |
2024-06-13 |
|
| 18 |
Hallal David |
Director |
24,200 |
2024-06-13 |
|
| 19 |
Van Hauwermeiren Timothy |
Director |
24,200 |
2024-06-13 |
|
| 20 |
Iannone Robert |
Director |
24,200 |
2024-06-13 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2025-06-10 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,883 |
$10.02 |
$439.71K |
| 2025-06-09 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.03 |
$440.14K |
| 2025-06-06 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.21 |
$448.04K |
| 2025-06-05 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,882 |
$10.15 |
$445.4K |
| 2025-06-04 |
Detheux Michel |
Chief Executive Officer |
Informierter Verkauf |
43,883 |
$10.10 |
$443.22K |
| 2025-06-06 |
Hallal David |
Director |
Optionsausübung (Verkauf) |
38,228 |
$4.30 |
$164.38K |
| 2025-06-05 |
Hallal David |
Director |
Informierter Verkauf |
38,227 |
$10.15 |
$388K |
| 2025-06-04 |
Hallal David |
Director |
Informierter Verkauf |
38,227 |
$10.07 |
$384.95K |
| 2025-05-15 |
Ecor1 Capital, Llc |
10 Percent Owner |
Informierter Kauf |
3,300,000 |
$8.00 |
$26.4M |
| 2025-05-14 |
Ecor1 Capital, Llc |
10 Percent Owner |
Informierter Kauf |
1,658,978 |
$7.41 |
$12.29M |
| 2025-05-13 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
Informierter Verkauf |
630,191 |
$8.06 |
$5.08M |
| 2025-05-13 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
Informierter Verkauf |
630,191 |
$8.06 |
$5.08M |
| 2025-05-13 |
Gadicke Ansbert |
Other: Former 10% Owner |
Informierter Verkauf |
1,031,931 |
$8.06 |
$8.32M |
| 2025-05-13 |
Van Hauwermeiren Timothy |
Director |
Optionsausübung (Verkauf) |
22,346 |
$4.30 |
$96.09K |
| 2025-05-13 |
Ecor1 Capital, Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
